Form 10-K405 - Annual report [Sections 13 and 15(d), S-K Item 405]:
SEC Accession No. 0000950135-00-005254
Filing Date
2000-11-22
Accepted
2000-11-22 00:00:00
Documents
4
Period of Report
2000-08-31

Document Format Files

Seq Description Document Type Size
1 GENOME THERAPEUTICS CORP. b37470gce10-k405.txt 10-K405 187368
2 CONSENT OF ARTHUR ANDERSEN LLP b37470gcex23.txt EX-23 663
3 RISK FACTORS b37470gcex99.txt EX-99 37824
4 FINANCIAL DATA SCHEDULE b37470gcex27.txt EX-27 2188
  Complete submission text file 0000950135-00-005254.txt   230107
Mailing Address 100 BEAVER STREET WALTHAM MA 02453
Business Address 1OO BEAVER ST WALTHAM MA 02453 7813982300
GENOME THERAPEUTICS CORP (Filer) CIK: 0000356830 (see all company filings)

EIN.: 042297484 | State of Incorp.: MA | Fiscal Year End: 0831
Type: 10-K405 | Act: 34 | File No.: 000-10824 | Film No.: 775913
SIC: 2835 In Vitro & In Vivo Diagnostic Substances